BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35469998)

  • 21. Management of Helicobacter pylori infections.
    Abadi AT; Kusters JG
    BMC Gastroenterol; 2016 Aug; 16(1):94. PubMed ID: 27520775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medicinal plant activity on Helicobacter pylori related diseases.
    Wang YC
    World J Gastroenterol; 2014 Aug; 20(30):10368-82. PubMed ID: 25132753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of Gastric Cancer: Eradication of Helicobacter Pylori and Beyond.
    Tsukamoto T; Nakagawa M; Kiriyama Y; Toyoda T; Cao X
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28771198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infections with
    Smith S; Fowora M; Pellicano R
    World J Gastroenterol; 2019 Jul; 25(25):3183-3195. PubMed ID: 31333310
    [No Abstract]   [Full Text] [Related]  

  • 25. Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients.
    Koosirirat C; Linpisarn S; Changsom D; Chawansuntati K; Wipasa J
    Int Immunopharmacol; 2010 Jul; 10(7):815-8. PubMed ID: 20438867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastric Cancer Risk in Patients with Helicobacter pylori Infection and Following Its Eradication.
    Rugge M
    Gastroenterol Clin North Am; 2015 Sep; 44(3):609-24. PubMed ID: 26314671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Helicobacter pylori-related diseases: dyspepsia, ulcers and gastric cancer].
    Gisbert JP
    Gastroenterol Hepatol; 2011 Oct; 34 Suppl 2():15-26. PubMed ID: 22330153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.
    Wu CY; Kuo KN; Wu MS; Chen YJ; Wang CB; Lin JT
    Gastroenterology; 2009 Nov; 137(5):1641-8.e1-2. PubMed ID: 19664631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.
    Lee YC; Chiang TH; Chou CK; Tu YK; Liao WC; Wu MS; Graham DY
    Gastroenterology; 2016 May; 150(5):1113-1124.e5. PubMed ID: 26836587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Helicobacter pylori eradication on incidence of gastric cancer in human and animal models: underlying biochemical and molecular events.
    Kabir S
    Helicobacter; 2009 Jun; 14(3):159-71. PubMed ID: 19702845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastroprotective effects of Hwanglyeonhaedok-tang against Helicobacter pylori-induced gastric cell injury.
    Park HS; Wijerathne CUB; Jeong HY; Seo CS; Ha H; Kwun HJ
    J Ethnopharmacol; 2018 Apr; 216():239-250. PubMed ID: 29410309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review: Pharmacological ins and outs of medicinal plants against Helicobacter pylori: A review.
    Zaidi SF; Muhammad JS; Usmanghani K; Sugiyama T
    Pak J Pharm Sci; 2015 May; 28(3 Suppl):1171-6. PubMed ID: 26051742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening and eradication of
    Liou JM; Malfertheiner P; Lee YC; Sheu BS; Sugano K; Cheng HC; Yeoh KG; Hsu PI; Goh KL; Mahachai V; Gotoda T; Chang WL; Chen MJ; Chiang TH; Chen CC; Wu CY; Leow AH; Wu JY; Wu DC; Hong TC; Lu H; Yamaoka Y; Megraud F; Chan FKL; Sung JJ; Lin JT; Graham DY; Wu MS; El-Omar EM;
    Gut; 2020 Dec; 69(12):2093-2112. PubMed ID: 33004546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibiotic resistance in Helicobacter pylori and molecular methods for the detection of resistance].
    Demiray E; Yilmaz O
    Mikrobiyol Bul; 2005 Jul; 39(3):399-408. PubMed ID: 16358500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer.
    Fuccio L; Zagari RM; Minardi ME; Bazzoli F
    Aliment Pharmacol Ther; 2007 Jan; 25(2):133-41. PubMed ID: 17229238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helicobacter pylori infection and gastric carcinogenesis in rodent models.
    Tsukamoto T; Toyoda T; Mizoshita T; Tatematsu M
    Semin Immunopathol; 2013 Mar; 35(2):177-90. PubMed ID: 23111700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin Encapsulated into Biocompatible Co-Polymer PLGA Nanoparticle Enhanced Anti-Gastric Cancer and Anti-Helicobacter Pylori Effect.
    Alam J; Dilnawaz F; Sahoo SK; Singh DV; Mukhopadhyay AK; Hussain T; Pati S
    Asian Pac J Cancer Prev; 2022 Jan; 23(1):61-70. PubMed ID: 35092372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Helicobacter pylori-related diseases].
    Gisbert JP
    Gastroenterol Hepatol; 2013 Oct; 36 Suppl 2():39-50. PubMed ID: 24160951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomedicine for the eradication of
    Garg A; Karhana S; Khan MA
    Future Microbiol; 2024 Mar; 19():431-447. PubMed ID: 38381027
    [No Abstract]   [Full Text] [Related]  

  • 40. What consideration should be given to Helicobacter pylori in treating nonsteroidal anti-inflammatory drug ulcers?
    Hawkey CJ
    Eur J Gastroenterol Hepatol; 2000 Jun; 12 Suppl 1():S17-20. PubMed ID: 10929894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.